{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T21:07:10Z","timestamp":1783631230277,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,10]]},"DOI":"10.7759\/cureus.52053","type":"journal-article","created":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T01:16:41Z","timestamp":1704935801000},"source":"Crossref","is-referenced-by-count":2,"title":["The Efficacy of Antihypertensive Drugs in Lowering Blood Pressure and Cardiovascular Events in the Elderly Population: A Systematic Review and Meta-Analysis"],"prefix":"10.7759","author":[{"given":"Raheel","family":"Chaudhry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuf A","family":"Siddique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Sebai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa M","family":"Moazam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghazala S","family":"Virk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonas","family":"Tamene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Hassouba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32008-2","article-title":"Modifiable risk factors, cardiovascular disease, and mortality in 155\u2008722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study","volume":"395","author":"Yusuf S","year":"2020","unstructured":"Yusuf S, Joseph P, Rangarajan S, et al.. Modifiable risk factors, cardiovascular disease, and mortality in 155\u2008722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. Lancet. 2020, 395:795-808. 10.1016\/S0140-6736(19)32008-2","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(02)11911-8","article-title":"Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies","volume":"360","year":"2002","unstructured":"Age-specific relevance of usual blood pressure to vascular mortality. a meta-analysis of individual data for one million adults in 61 prospective studies. The Lancet . 2002, 360:1903-13. 10.1016\/s0140-6736(02)11911-8","journal-title":"The Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60685-1","article-title":"Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1\u00b725 million people","volume":"383","author":"Rapsomaniki E","year":"2014","unstructured":"Rapsomaniki E, Timmis A, George J, et al.. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1\u00b725 million people. Lancet. 2014, 383:1899-911. 10.1016\/S0140-6736(14)60685-1","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.13551","article-title":"Association of blood pressure classification in young adults using the 2017 American College of Cardiology\/American Heart Association blood pressure guideline with cardiovascular events later in life","volume":"320","author":"Yano Y","year":"2018","unstructured":"Yano Y, Reis JP, Colangelo LA, et al.. Association of blood pressure classification in young adults using the 2017 American College of Cardiology\/American Heart Association blood pressure guideline with cardiovascular events later in life. JAMA. 2018, 320:1774-82. 10.1001\/jama.2018.13551","journal-title":"JAMA"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhin.2017.08.010","article-title":"Controlling catheter-related bloodstream infections through a multi-centre educational programme for intensive care units","volume":"97","author":"Musu M","year":"2017","unstructured":"Musu M, Finco G, Mura P, et al.. Controlling catheter-related bloodstream infections through a multi-centre educational programme for intensive care units. J Hosp Infect. 2017, 97:275-81. 10.1016\/j.jhin.2017.08.010","journal-title":"J Hosp Infect"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1161\/HYP.0000000000000067","article-title":"Systematic review for the 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines","volume":"71","author":"Reboussin DM","year":"2018","unstructured":"Reboussin DM, Allen NB, Griswold ME, et al.. Systematic review for the 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines. Hypertension. 2018, 71:e116-35. 10.1161\/HYP.0000000000000067","journal-title":"Hypertension"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"9859","author":"Lozano R","year":"2012","unstructured":"Lozano R, Naghavi M, Foreman K, et al.. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet . 2012, 9859:2095-128. 10.1016\/S0140-6736(12)61728-0","journal-title":"The Lancet"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61689-4","article-title":"Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"9859","author":"Murray CJL","year":"2012","unstructured":"Murray CJL, Vos T, Lozano R, et al.. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet . 2012, 9859:2197-223. 10.1016\/S0140-6736(12)61689-4","journal-title":"The Lancet"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000350","article-title":"Heart disease and Stroke Statistics-2016 update: a report from the American Heart Association","volume":"133","author":"Mozaffarian D","year":"2016","unstructured":"Mozaffarian D, Benjamin EJ, Go AS, et al.. Heart disease and Stroke Statistics-2016 update: a report from the American Heart Association. Circulation. 2016, 133:e38-360. 10.1161\/CIR.0000000000000350","journal-title":"Circulation"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31919-5","article-title":"Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19\u00b71 million participants","volume":"389","year":"2017","unstructured":"Worldwide trends in blood pressure from 1975 to 2015. a pooled analysis of 1479 population-based measurement studies with 19\u00b71 million participants. Lancet. 2017, 389:37-55. 10.1016\/S0140-6736(16)31919-5","journal-title":"Lancet"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.116.09390","article-title":"Blood pressure, antihypertensive polypharmacy, frailty, and risk for serious fall injuries among older treated adults with hypertension","volume":"70","author":"Bromfield SG","year":"2017","unstructured":"Bromfield SG, Ngameni CA, Colantonio LD, et al.. Blood pressure, antihypertensive polypharmacy, frailty, and risk for serious fall injuries among older treated adults with hypertension. Hypertension. 2017, 70:259-66. 10.1161\/HYPERTENSIONAHA.116.09390","journal-title":"Hypertension"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2014.8012","article-title":"Treatment with multiple blood pressure medications, achieved blood pressure, and mortality in older nursing home residents: the PARTAGE study","volume":"175","author":"Benetos A","year":"2015","unstructured":"Benetos A, Labat C, Rossignol P, et al.. Treatment with multiple blood pressure medications, achieved blood pressure, and mortality in older nursing home residents: the PARTAGE study. JAMA Intern Med. 2015, 175:989-95. 10.1001\/jamainternmed.2014.8012","journal-title":"JAMA Intern Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.16755","article-title":"The 2018 European Society of Cardiology\/European Society of hypertension and 2017 American College of Cardiology\/American Heart Association blood pressure guidelines: more similar than different","volume":"320","author":"Whelton PK","year":"2018","unstructured":"Whelton PK, Williams B. The 2018 European Society of Cardiology\/European Society of hypertension and 2017 American College of Cardiology\/American Heart Association blood pressure guidelines: more similar than different. JAMA. 2018, 320:1749-50. 10.1001\/jama.2018.16755","journal-title":"JAMA"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.18574","article-title":"Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis","volume":"313","author":"Emdin CA","year":"2015","unstructured":"Emdin CA, Rahimi K, Neal B, Callender T, Perkovic V, Patel A. Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis. JAMA. 2015, 313:603-15. 10.1001\/jama.2014.18574","journal-title":"JAMA"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-10-33","article-title":"Comparative effectiveness of antihypertensive medication for primary prevention of cardiovascular disease: systematic review and multiple treatments meta-analysis","volume":"10","author":"Fretheim A","year":"2012","unstructured":"Fretheim A, Odgaard-Jensen J, Br\u00f8rs O, et al.. Comparative effectiveness of antihypertensive medication for primary prevention of cardiovascular disease: systematic review and multiple treatments meta-analysis. BMC Med. 2012, 10:33. 10.1186\/1741-7015-10-33","journal-title":"BMC Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000092488.40085.15","article-title":"Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review","volume":"34","author":"Rashid P","year":"2003","unstructured":"Rashid P, Leonardi-Bee J, Bath P. Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review. Stroke. 2003, 34:2741-8. 10.1161\/01.STR.0000092488.40085.15","journal-title":"Stroke"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0000000000000024","article-title":"Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"45","author":"Kernan WN","year":"2014","unstructured":"Kernan WN, Ovbiagele B, Black HR, et al.. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2014, 45:2160-236. 10.1161\/STR.0000000000000024","journal-title":"Stroke"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.7050","article-title":"Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged \u226575 years: a randomized clinical trial","volume":"315","author":"Williamson JD","year":"2016","unstructured":"Williamson JD, Supiano MA, Applegate WB, et al.. Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged \u226575 years: a randomized clinical trial. JAMA. 2016, 315:2673-82. 10.1001\/jama.2016.7050","journal-title":"JAMA"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins JP","year":"2011","unstructured":"Higgins JP, Altman DG, G\u00f8tzsche PC, et al.. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011, 343:d5928. 10.1136\/bmj.d5928","journal-title":"BMJ"},{"key":"ref20","unstructured":"Review Manager (RevMan) Version 5.4. (2020). https.\/\/training.cochrane.org\/system\/files\/uploads\/protected_file\/RevMan5.4_user_guide.pdf."},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61242-8","article-title":"Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial","volume":"372","year":"2008","unstructured":"Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors. a randomised controlled trial. The Lancet . 2008, 372:1174-83. 10.1016\/S0140-6736(08)61242-8","journal-title":"The Lancet"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1080\/08037050510008823","article-title":"The study on cognition and prognosis in the elderly (SCOPE) - major CV events and stroke in subgroups of patients","volume":"14","author":"Trenkwalder P","year":"2005","unstructured":"Trenkwalder P, Dag Elmfeldt, Hofman A, et al.. The study on cognition and prognosis in the elderly (SCOPE) - major CV events and stroke in subgroups of patients. Blood Press. 2005, 14:31-7. 10.1080\/08037050510008823","journal-title":"Blood Press"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200305000-00011","article-title":"The study on cognition and prognosis in the elderly (SCOPE): principal results of a randomized double-blind intervention trial","volume":"21","author":"Lithell H","year":"2003","unstructured":"Lithell H, Hansson L, Skoog I, et al.. The study on cognition and prognosis in the elderly (SCOPE): principal results of a randomized double-blind intervention trial. J Hypertens. 2003, 21:875-86. 10.1097\/00004872-200305000-00011","journal-title":"J Hypertens"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0804593","article-title":"Telmisartan to prevent recurrent stroke and cardiovascular events","volume":"359","author":"Yusuf S","year":"2008","unstructured":"Yusuf S, Diener HC, Sacco RL, et al.. Telmisartan to prevent recurrent stroke and cardiovascular events. N Engl J Med. 2008, 359:1225-37. 10.1056\/NEJMoa0804593","journal-title":"N Engl J Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1001121","article-title":"Effect of valsartan on the incidence of diabetes and cardiovascular events","volume":"362","author":"McMurray JJ","year":"2010","unstructured":"McMurray JJ, Holman RR, Haffner SM, et al.. Effect of valsartan on the incidence of diabetes and cardiovascular events. N Engl J Med. 2010, 362:1477-90. 10.1056\/NEJMoa1001121","journal-title":"N Engl J Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0805450","article-title":"Irbesartan in patients with heart failure and preserved ejection fraction","volume":"359","author":"Massie BM","year":"2008","unstructured":"Massie BM, Carson PE, McMurray JJ, et al.. Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med. 2008, 359:2456-67. 10.1056\/NEJMoa0805450","journal-title":"N Engl J Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0805710","article-title":"Valsartan for prevention of recurrent atrial fibrillation","volume":"360","author":"Disertori M","year":"2009","unstructured":"Disertori M, Latini R, Barlera S, et al.. Valsartan for prevention of recurrent atrial fibrillation. N Engl J Med. 2009, 360:1606-17. 10.1056\/NEJMoa0805710","journal-title":"N Engl J Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1008816","article-title":"Irbesartan in patients with atrial fibrillation","volume":"364","author":"Yusuf S","year":"2011","unstructured":"Yusuf S, Healey JS, Pogue J, et al.. Irbesartan in patients with atrial fibrillation. N Engl J Med. 2011, 364:928-38. 10.1056\/NEJMoa1008816","journal-title":"N Engl J Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients","volume":"342","author":"Yusuf S","year":"2000","unstructured":"Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med. 2000, 342:145-53. 10.1056\/NEJM200001203420301","journal-title":"N Engl J Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14286-9","article-title":"Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)","volume":"362","year":"2003","unstructured":"Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease. randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). The Lancet. 2003, 362:782-8. 10.1016\/S0140-6736(03)14286-9","journal-title":"The Lancet"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.158.15.1681","article-title":"Subgroup and per-protocol analysis of the randomized European trial on isolated systolic hypertension in the elderly","volume":"158","author":"Staessen JA","year":"1998","unstructured":"Staessen JA, Fagard R, Thijs L, et al.. Subgroup and per-protocol analysis of the randomized European trial on isolated systolic hypertension in the elderly. Arch Intern Med. 1998, 158:1681-91. 10.1001\/archinte.158.15.1681","journal-title":"Arch Intern Med"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)05381-6","article-title":"Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension","volume":"350","author":"Staessen JA","year":"1997","unstructured":"Staessen JA, Fagard R, Thijs L, et al.. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Lancet. 1997, 350:757-64. 10.1016\/S0140-6736(97)05381-6","journal-title":"The Lancet"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199816120-00016","article-title":"Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group","volume":"16","author":"Liu L","year":"1998","unstructured":"Liu L, Wang JG, Gong L, Liu G, Staessen JA. Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group. J Hypertens. 1998, 16:1823-9. 10.1097\/00004872-199816120-00016","journal-title":"J Hypertens"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1097\/01.hjh.0000160223.94220.29","article-title":"Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with symptomatic stable angina and hypertension: the ACTION trial","volume":"23","author":"Lubsen J","year":"2005","unstructured":"Lubsen J, Wagener G, Kirwan BA, de Brouwer S, Poole-Wilson PA. Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with symptomatic stable angina and hypertension: the ACTION trial. J Hypertens. 2005, 23:641-8. 10.1097\/01.hjh.0000160223.94220.29","journal-title":"J Hypertens"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)90089-7","article-title":"Prevention of stroke","volume":"352","author":"Wolf PA","year":"1998","unstructured":"Wolf PA. Prevention of stroke. The Lancet. 1998, 352:15-8. 10.1016\/S0140-6736(98)90089-7","journal-title":"The Lancet"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.304.6824.405","article-title":"Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party","volume":"304","year":"1992","unstructured":"Medical Research Council trial of treatment of hypertension in older adults. principal results. MRC Working Party. BMJ. 1992, 304:405-12. 10.1136\/bmj.304.6824.405","journal-title":"BMJ"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200312000-00030","article-title":"Results of the pilot study for the hypertension in the very elderly trial","volume":"21","author":"Bulpitt CJ","year":"2003","unstructured":"Bulpitt CJ, Beckett NS, Cooke J, et al.. Results of the pilot study for the hypertension in the very elderly trial. J Hypertens. 2003, 21:2409-17. 10.1097\/00004872-200312000-00030","journal-title":"J Hypertens"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0801369","article-title":"Treatment of hypertension in patients 80 years of age or older","volume":"358","author":"Beckett NS","year":"2008","unstructured":"Beckett NS, Peters R, Fletcher AE, et al.. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008, 358:1887-98. 10.1056\/NEJMoa0801369","journal-title":"N Engl J Med"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000001777","article-title":"Effects of blood pressure-lowering treatment on cardiovascular outcomes and mortality: 14 - effects of different classes of antihypertensive drugs in older and younger patients: overview and meta-analysis","volume":"36","author":"Thomopoulos C","year":"2018","unstructured":"Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure-lowering treatment on cardiovascular outcomes and mortality: 14 - effects of different classes of antihypertensive drugs in older and younger patients: overview and meta-analysis. J Hypertens. 2018, 36:1637-47. 10.1097\/HJH.0000000000001777","journal-title":"J Hypertens"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2019-00197","article-title":"Antihypertensive agents in older adults: a systematic review and meta-analysis of randomized clinical trials","volume":"104","author":"Murad MH","year":"2019","unstructured":"Murad MH, Larrea-Mantilla L, Haddad A, et al.. Antihypertensive agents in older adults: a systematic review and meta-analysis of randomized clinical trials. J Clin Endocrinol Metab. 2019, 104:1575-84. 10.1210\/jc.2019-00197","journal-title":"J Clin Endocrinol Metab"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000001720","article-title":"Blood pressure-lowering drugs and secondary prevention of cardiovascular disease: systematic review and meta-analysis","volume":"36","author":"Xie W","year":"2018","unstructured":"Xie W, Zheng F, Evangelou E, et al.. Blood pressure-lowering drugs and secondary prevention of cardiovascular disease: systematic review and meta-analysis. J Hypertens. 2018, 36:1256-65. 10.1097\/HJH.0000000000001720","journal-title":"J Hypertens"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01225-8","article-title":"Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis","volume":"387","author":"Ettehad D","year":"2016","unstructured":"Ettehad D, Emdin CA, Kiran A, et al.. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. The Lancet. 2016, 387:957-67. 10.1016\/S0140-6736(15)01225-8","journal-title":"The Lancet"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/216814-the-efficacy-of-antihypertensive-drugs-in-lowering-blood-pressure-and-cardiovascular-events-in-the-elderly-population-a-systematic-review-and-meta-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:11:24Z","timestamp":1707509484000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/216814-the-efficacy-of-antihypertensive-drugs-in-lowering-blood-pressure-and-cardiovascular-events-in-the-elderly-population-a-systematic-review-and-meta-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,10]]},"references-count":42,"URL":"https:\/\/doi.org\/10.7759\/cureus.52053","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,10]]}}}